Postmarket surveillance data revealed that enfortumab vedotin (EV) skin toxicity is associated with high hospitalization and ...
In the fight against disease, programmed cell death - also known as apoptosis - is a key protective function of the body. It breaks down cells that ...
LANZHOU -- Chinese researchers have revealed the heart-protective effect of nicotinamide — a derivative of B vitamins — in ...
Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.
News-Medical.Net on MSN
Researchers identify new molecular switch involved in programmed cell death
In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes.
Asianet Newsable on MSN
Triple Therapy Forces Leukemia Cells Into Necroptosis, Boosting Immune Attack
A new study finds that three existing drugs can force leukemia cells into necroptosis, activating a strong immune response.
Radiopharm completes enrollment for second cohort of patients in phase 1 dose escalation trial of 177Lu-RAD204 in PD-L1 positive advanced cancers: Sydney Saturday, November 15, 20 ...
LANZHOU, Nov. 5 (Xinhua) -- Chinese researchers have revealed the heart-protective effect of nicotinamide -- a derivative of B vitamins -- in exploring the mechanisms of related cardiotoxicity in ...
Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results